IBM Micromedex Drug Interact
source

IBM Micromedex Drug Interact

Price
Free
Category
Medical Health & Fitness
Last update
Sep 03, 2021
Publisher
View in store
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Loading...

Description

1564 chars

IBM Micromedex® Drug Int. (Outside the US and Canada) is a free resource for IBM Micromedex® customers. With Drug Interactions, clinicians can check a patient’s entire medication list simultaneously for potentially harmful interactions and view severity ratings that range from contraindicated to minor. This app provides insight into: •Why the drugs in question interact •How the results of those interactions will present in the patient •Recommendations for monitoring patient outcomes. IBM Micromedex Drug Int. is a reliable resource for on-the-go access to the industry’s most trusted clinical reference information, providing users with more informed treatment decisions at the point of care. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere. IBM Micromedex® customers simply follow these instructions to obtain a password: 1.Login to IBM Micromedex® through your subscribing facility 2.Click on the “Download Center” link near the top of the application 3.Refer to the detailed downloading instructions, which include your password for activating the application at no charge. Not sure if your institution subscribes to IBM Micromedex® via the internet? Check with your Director of Pharmacy, Medical Librarian, or anyone else at your facility responsible for clinical reference information. If you cannot locate the “Download Center” link or are having problems with your password, please contact support at https://www.ibm.com/support/home/pages/support-guide/?product=4592217

Screenshots

https://is4-ssl.mzstatic.com/image/thumb/Purple123/v4/4b/0e/d9/4b0ed9ea-ce0f-0df6-e4d5-c9daca6c9639/mzl.tkumweze.png/640x1136bb.pnghttps://is4-ssl.mzstatic.com/image/thumb/Purple123/v4/89/ff/8a/89ff8a0b-f98a-9cd7-a553-9316f4a5111a/mzl.rdxdthxy.png/640x1136bb.pnghttps://is2-ssl.mzstatic.com/image/thumb/Purple113/v4/78/29/06/78290623-e1df-3a8e-0fc5-b30556a5be22/mzl.ejjczrqk.png/640x1136bb.pnghttps://is3-ssl.mzstatic.com/image/thumb/Purple113/v4/09/4e/5e/094e5e5d-29d5-c86d-4549-8b3dd609fa5c/mzl.elfbwygm.png/640x1136bb.pnghttps://is3-ssl.mzstatic.com/image/thumb/Purple123/v4/1c/2d/84/1c2d84aa-15dc-e8e9-f549-b8815088359d/mzl.raqvdwdk.png/640x1136bb.png
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster